Barrow, Hanley, Mewhinney & Strauss
MDXG icon

Barrow, Hanley, Mewhinney & Strauss’s MiMedx Group MDXG Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-336
Closed -$2.05K – 371
2025
Q2 		$2.05K Buy
+336
New +$2.23K ﹤0.01% 294

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's MDXG Position: Q3 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of MiMedx Group (MDXG) in Q3 2025, closing a stake of 336 shares — an estimated $2.05K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in MDXG in Q2 2025 and held it in 1 quarter. The position peaked at $2.05K in Q2 2025. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining MiMedx Group position as of Q3 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 336 MiMedx Group shares in Q3 2025, an estimated $2.05K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in MiMedx Group in Q2 2025 and held it in 1 quarter.
  • Barrow, Hanley, Mewhinney & Strauss's MiMedx Group position peaked at $2.05K in Q2 2025.
  • 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q3 2025, filed 13 Nov 2025.